Incidence, consequences, and predictors of serious chemotherapy-induced thrombocytopenia in nasopharyngeal carcinoma

被引:1
|
作者
Zhang, Lu-Lu [1 ]
Chen, Xi [1 ]
Huang, Ying-Ying [1 ]
Liang, Chi-Xiong [1 ]
Qiang, Meng-Yun [2 ]
Cai, Zhuo-Chen [1 ]
Zhan, Ze-Jiang [1 ]
Deng, Ying [1 ]
Zhou, Jia-Yu [1 ]
Huang, Hao-Yang [1 ]
Guo, Xiang [1 ,3 ]
Lv, Xing [1 ,3 ]
机构
[1] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Nasopharyngeal Carcinoma, State Key Lab Oncol South China,Canc Ctr,Guangdong, Guangzhou, Peoples R China
[2] Chinese Acad Sci, Univ Chinese Acad Sci, Zhejiang Canc Hosp, Inst Basic Med & Canc IBMC,Canc Hosp,Dept Head & N, Hangzhou, Peoples R China
[3] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Nasopharyngeal Carcinoma, State Key Lab Oncol South China,Canc Ctr,Key Lab O, 651 Dongfeng East Rd, Guangzhou, Guangdong, Peoples R China
来源
CANCER MEDICINE | 2023年 / 12卷 / 13期
基金
中国国家自然科学基金;
关键词
chemotherapy; nasopharyngeal carcinoma; predictor; thrombocytopenia; RADIATION TREATMENT TIME; SQUAMOUS-CELL HEAD; INDUCTION CHEMOTHERAPY; INDUCED NEUTROPENIA; NECK-CANCER; PLATELET TRANSFUSION; POOLED ANALYSIS; STAGE-III; CISPLATIN; SURVIVAL;
D O I
10.1002/cam4.6062
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: This study aimed to investigate the incidence, consequences, and predictors of serious chemotherapy--induced thrombocytopenia (CIT) in nasopharyngeal carcinoma (NPC). Materials and Methods: We retrospectively reviewed the clinical records of patients with NPC between 2013 and 2015. Multivariate Cox proportional hazards regression model and propensity score matching were used to estimate the effect of serious CIT on overall survival. Univariate and multivariate logistic regression analyses were applied to identify the predictors of serious CIT. Results and Conclusion: The incidence of serious CIT was 5.21% in patients with NPC. Patients who experienced serious thrombocytopenia had a worse long-term prognosis, while the difference in short-term survival rate was slight. Chemotherapy regimens of gemcitabine and platinum, 5-fluorouracil and platinum, taxane and platinum, serum potassium ion concentration, serum lactate dehydrogenase levels, platelet count, red blood cell count, and estimated glomerular filtration rate were predictors of serious CIT.
引用
收藏
页码:14084 / 14093
页数:10
相关论文
共 50 条
  • [31] Chemotherapy-induced anemia in adults: Incidence and treatment
    Groopman, JE
    Itri, LM
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (19): : 1616 - 1634
  • [32] Chemotherapy-induced cardiotoxicity: Incidence, diagnosis and prevention
    Nelson-Veniard, Marie
    Thambo, Jean-Benoit
    BULLETIN DU CANCER, 2015, 102 (7-8) : 622 - 626
  • [33] Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis
    Seretny, Marta
    Currie, Gillian L.
    Sena, Emily S.
    Ramnarine, Sabrina
    Grant, Robin
    MacLeod, Malcolm R.
    Colvin, Leslie A.
    Fallon, Marie
    PAIN, 2014, 155 (12) : 2461 - 2470
  • [34] Use of romiplostim in chemotherapy-induced thrombocytopenia in gynecologic and breast cancers
    Moufarrij, Sara
    O'Cearbhaill, Roisin
    Zhou, Qin
    Iasonos, Alexia
    Mantha, Simon
    Wilkins, Cy
    GYNECOLOGIC ONCOLOGY, 2023, 173 : S16 - S17
  • [35] A single center experience with romiplostim for the management of chemotherapy-induced thrombocytopenia
    Miao, Jennifer
    Leblebjian, Houry
    Scullion, Bridget
    Parnes, Aric
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (04) : E86 - E88
  • [36] CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA AND CLINICAL BLEEDING IN PATIENTS WITH GYNECOLOGIC MALIGNANCY
    Hashiguchi, Y.
    ANNALS OF ONCOLOGY, 2012, 23 : 506 - 507
  • [37] Romiplostim for chemotherapy-induced thrombocytopenia: Efficacy and safety of extended use
    Wilkins, Cy R.
    Ortiz, Jocelyn
    Gilbert, Leah J.
    Yin, Shen
    Mones, Jodi, V
    Parameswaran, Rekha
    Mantha, Simon
    Soff, Gerald A.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2022, 6 (03)
  • [38] Thrombopoietin receptor agonist antibody for treating chemotherapy-induced thrombocytopenia
    Shin, Jiwon
    Kim, Min-Jung
    Quan, Xingguo
    Kim, Ji Woong
    Lee, Sukmook
    Park, SaeGwang
    Jeong, Jee-Yeong
    Yea, Kyungmoo
    BMC CANCER, 2023, 23 (01)
  • [39] Chemotherapy-induced thrombocytopenia and clinical bleeding in patients with gynecologic malignancy
    Hashiguchi, Y.
    Fukuda, T.
    Ichimura, T.
    Matsumoto, Y.
    Yasui, T.
    Sumi, T.
    Ishiko, O.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2015, 36 (02) : 168 - 173
  • [40] CLINICAL IMPACT OF CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA IN PATIENTS WITH GYNECOLOGIC CANCER
    GOLDBERG, GL
    GIBBON, DG
    SMITH, HO
    DEVICTORIA, C
    RUNOWICZ, CD
    BURNS, ER
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (11) : 2317 - 2320